• Friday, April 28, 2023
Peter Lawson Maintained (SWTX) at Buy with Decreased Target to $41 on, Apr 28th, 2023
Peter Lawson of Barclays, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Decreased Target from $55 to $41 on, Apr 28th, 2023.
Peter has made no other calls on SWTX in the last 4 months.
There are 3 other peers that have a rating on SWTX. Out of the 3 peers that are also analyzing SWTX, 0 agree with Peter's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Peter
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $105 on, Thursday, April 20th, 2023
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $57 on, Tuesday, March 7th, 2023
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $45 on, Thursday, January 26th, 2023